Latest news, press releases, and SEC filings for Tvardi Therapeutics Inc (TVRD) https://caymanjournal.com/stock/TVRD en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Mon, 27 Apr 2026 20:21:22 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 # 🧾 What This Document Is This is an Annual Report to Shareholders (ARS), a comprehensive yearly update that public companies must send to their investors. Think of it as a "state of the union" for the business, covering strategy, financial performance, and future plans. It's more detailed than a q https://caymanjournal.com/stock/TVRD/sec-filing/0001104659-26-047713 https://caymanjournal.com/stock/TVRD/sec-filing/0001104659-26-047713 Thu, 23 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is an 8-K filing, which is a report of major events that shareholders should know about. Specifically, this filing includes an **Exhibit 99.1**, which is a press release from Tvardi Therapeutics. It combines their **fourth quarter and full-year 2025 financial results* https://caymanjournal.com/stock/TVRD/sec-filing/0001104659-26-037724 https://caymanjournal.com/stock/TVRD/sec-filing/0001104659-26-037724 Tue, 31 Mar 2026 00:00:00 GMT SEC Filing